Which has grown faster, CDXS or VYGR?

Over the past five years, CDXS grew revenue faster — CDXS at a 0.38% CAGR versus VYGR at -23.59%.

How have CDXS and VYGR total returns compared?

Over the past 10 years, CDXS delivered -11.05% and VYGR delivered -14.87% annualized total return. Past performance doesn't predict future results.

Codexis, Inc. (CDXS) vs Voyager Therapeutics, Inc. (VYGR)

A side-by-side comparison of Codexis, Inc. and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CDXS

Codexis, Inc.

$146M

$1.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VYGR

Voyager Therapeutics, Inc.

$149M

$2.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CDXS vs VYGR

growth of $100 · dividends reinvested · last 10y

CDXS -68.6% (-10.9%/yr)VYGR -79.2% (-14.5%/yr)CDXS compounded faster over this window

CDXS VYGR

CDXS vs VYGR: by the numbers

•VYGR is the larger company ($149M vs $146M market cap).
•Both run net losses; CDXS's is the smaller (-39.55% vs -312.63% net margin).
•CDXS grew revenue faster over the past five years (0.38% vs -23.59% CAGR).

Metrics side by side

Valuation

Metric	CDXS	VYGR
P/S ratio	1.88	4.31
P/B ratio	4.44	0.96

Profitability

Metric	CDXS	VYGR
Gross margin	83.71%	-227.62%
Operating margin	-54.46%	-326.56%
Net margin	-39.55%	-312.63%
ROE	-93.22%	-69.78%
ROIC	-23.41%	-64.72%

Growth (annualized)

Metric	CDXS	VYGR
Revenue CAGR (5Y)	0.38%	-23.59%
Total return CAGR (5Y)	-44.64%	-0.08%

Frequently asked

Which has grown faster, CDXS or VYGR?: Over the past five years, CDXS grew revenue faster — CDXS at a 0.38% CAGR versus VYGR at -23.59%.
How have CDXS and VYGR total returns compared?: Over the past 10 years, CDXS delivered -11.05% and VYGR delivered -14.87% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CDXS analysis Full VYGR analysis Interactive comparison tool

Dig into the metrics

Codexis ROE Voyager Therapeutics ROE Codexis operating margin Voyager Therapeutics operating margin Codexis revenue growth Voyager Therapeutics revenue growth Codexis free cash flow Voyager Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.